Nasdaq: MDGL/Biotechnology
Madrigal Pharmaceuticals, Inc.
West Conshohocken, PA, United States
Company overview
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
This profile is for informational purposes only and is not investment advice. Company information may change after the verification date.